Qube Research & Technologies LTD Genmab A/S Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Genmab A/S stock. As of the latest transaction made, Qube Research & Technologies LTD holds 114,523 shares of GMAB stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,523

Previous 237,956 51.87%

Holding current value

$2.69 Million

Previous $7.12 Million 59.58%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $3.1 Million - $3.74 Million	-123,433 Reduced 51.87%	114,523 $2.88 Million
Q1 2024 May 14, 2024	SELL	$26.43 - $32.77 $506,398 - $627,873	-19,160 Reduced 7.45%	237,956 $7.12 Million
Q4 2023 Feb 13, 2024	BUY	$27.94 - $35.44 $3.55 Million - $4.5 Million	127,109 Added 97.77%	257,116 $8.19 Million
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $3.51 Million - $4.2 Million	-99,442 Reduced 43.34%	130,007 $4.59 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $1.64 Million - $1.89 Million	-43,954 Reduced 16.08%	229,449 $8.72 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $4.03 Million - $5 Million	-115,678 Reduced 29.73%	273,403 $10.3 Million
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $13.2 Million - $18.3 Million	389,081 New	389,081 $16.5 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $622,402 - $894,746	-23,198 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$30.95 - $39.68 $497,861 - $638,292	-16,086 Reduced 40.95%	23,198 $839,000
Q4 2021 Feb 01, 2022	BUY	$35.87 - $47.12 $881,792 - $1.16 Million	24,583 Added 167.22%	39,284 $1.55 Million
Q3 2021 Nov 12, 2021	SELL	$41.55 - $48.72 $357,911 - $419,674	-8,614 Reduced 36.95%	14,701 $642,000
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $766,597 - $1.04 Million	23,315 New	23,315 $952,000
Q1 2021 May 14, 2021	SELL	$30.92 - $44.4 $939,442 - $1.35 Million	-30,383 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.66 - $40.76 $419,369 - $507,828	12,459 Added 69.51%	30,383 $1.24 Million
Q3 2020 Nov 12, 2020	BUY	$33.07 - $38.68 $592,746 - $693,300	17,924 New	17,924 $656,000

Others Institutions Holding GMAB

# of Institutions

232

Shares Held

48.5M

Call Options Held

6.8K

Put Options Held

27.6K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $15.5B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Genmab A/S Transaction History